617 related articles for article (PubMed ID: 33001713)
1. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
Uguz F
Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
[No Abstract] [Full Text] [Related]
2. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
5. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.
Reefhuis J; Devine O; Friedman JM; Louik C; Honein MA;
BMJ; 2015 Jul; 351():h3190. PubMed ID: 26156519
[TBL] [Abstract][Full Text] [Related]
6. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
Eke AC; Saccone G; Berghella V
BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
[TBL] [Abstract][Full Text] [Related]
8. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.
Yazdy MM; Mitchell AA; Louik C; Werler MM
Epidemiology; 2014 Nov; 25(6):859-65. PubMed ID: 25171134
[TBL] [Abstract][Full Text] [Related]
9. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
[TBL] [Abstract][Full Text] [Related]
10. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
Womersley K; Ripullone K; Agius M
Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843
[TBL] [Abstract][Full Text] [Related]
11. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.
Myles N; Newall H; Ward H; Large M
Aust N Z J Psychiatry; 2013 Nov; 47(11):1002-12. PubMed ID: 23761574
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
13. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
Gentile S
Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
Pedersen LH; Henriksen TB; Vestergaard M; Olsen J; Bech BH
BMJ; 2009 Sep; 339():b3569. PubMed ID: 19776103
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
Kulin NA; Pastuszak A; Sage SR; Schick-Boschetto B; Spivey G; Feldkamp M; Ormond K; Matsui D; Stein-Schechman AK; Cook L; Brochu J; Rieder M; Koren G
JAMA; 1998 Feb; 279(8):609-10. PubMed ID: 9486756
[TBL] [Abstract][Full Text] [Related]
17. Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies.
Wang S; Yang L; Wang L; Gao L; Xu B; Xiong Y
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25991012
[TBL] [Abstract][Full Text] [Related]
18. Sertraline use during pregnancy and the risk of major malformations.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
[TBL] [Abstract][Full Text] [Related]
19. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
Orsolini L; Bellantuono C
Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
[TBL] [Abstract][Full Text] [Related]
20. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.
Reis M; Källén B
Psychol Med; 2010 Oct; 40(10):1723-33. PubMed ID: 20047705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
